You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lynparza

Showing 1 - 25 of 155
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

LYNPARZA Breast Cancer in Adjuvant Setting Japan Post-Marketing

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jan 9, 2023

    EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

    Recruiting
    • EGFR-Mutated Non-Small-Cell Lung Carcinoma
    • Small Cell/Neuroendocrine
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Renal Cell Carcinoma, Ovarian Carcinoma, Thyroid Carcinoma Trial in Groningen (Olaparib, Lenvatinib, Sunitinib)

    Not yet recruiting
    • Renal Cell Carcinoma
    • +4 more
    • Groningen, Netherlands
      University Medical Center Groningen
    Jul 13, 2023

    Metastatic Breast Cancer Trial (Olaparib, 17b-estradiol)

    Not yet recruiting
    • Metastatic Breast Cancer
    • (no location specified)
    Jun 2, 2023

    Neuroendocrine Tumors, Peptide Receptor Radionuclide Therapy Trial in Rotterdam (olaparib)

    Recruiting
    • Neuroendocrine Tumors
    • Peptide Receptor Radionuclide Therapy
    • Rotterdam, South Holland, Netherlands
      Erasmus MC
    May 19, 2023

    Ovarian Cancer, Breast Cancer Trial in Vijayawada (Olaparib tablets, 150 mg, Lynparza® (olaparib) tablets 150 mg)

    Recruiting
    • Ovarian Cancer
    • Breast Cancer
    • Olaparib tablets, 150 mg
    • Lynparza® (olaparib) tablets 150 mg
    • Vijayawada, Andhra Pradesh, India
      Sandoz Investigative Site
    Apr 12, 2022

    Ovarian Cancer Trial in Pittsburgh (Olaparib tablet)

    Not yet recruiting
    • Ovarian Cancer
    • Olaparib tablet
    • Pittsburgh, Pennsylvania
      UPMC Hillman Cancer Center
    Nov 1, 2023

    Recurrent Metastatic Melanoma, Cutaneous Melanoma, Mucosal Melanoma Trial in Boston (Olaparib)

    Not yet recruiting
    • Recurrent Metastatic Melanoma
    • +3 more
    • Boston, Massachusetts
    • +1 more
    Jul 29, 2022

    Carcinoma, Ovarian Epithelial Trial in San Fermo Della Battaglia, Padova (Olaparib, Bevacizumab)

    Recruiting
    • Carcinoma, Ovarian Epithelial
    • San Fermo Della Battaglia, Como, Italy
    • +1 more
    Nov 2, 2023

    Ovarian Cancer, Breast Cancer Trial in Dallas (Lynparza)

    Active, not recruiting
    • Ovarian Cancer
    • Breast Cancer
    • Lynparza
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Mar 22, 2022

    Breast Cancer Trial in Boston, Cambridge (Sapacitabine, Olaparib)

    Active, not recruiting
    • Breast Cancer
    • Boston, Massachusetts
    • +1 more
    May 2, 2022

    Prostate Cancer Trial in Lexington (biological, drug, radiation)

    Not yet recruiting
    • Prostate Cancer
    • Pembrolizumab
    • +3 more
    • Lexington, Kentucky
      University of Kentucky
    Oct 3, 2022

    Breast Cancer Trial in Los Angeles (Pembrolizumab, Olaparib)

    Active, not recruiting
    • Breast Cancer
    • Los Angeles, California
      Cedars-Sinai Medical Center
    Feb 1, 2023

    Advanced Breast Cancer Trial in Spain (Olaparib [Lynparza®] plus Trastuzumab [Herceptin®])

    Terminated
    • Advanced Breast Cancer
    • Olaparib [Lynparza®] plus Trastuzumab [Herceptin®]
    • Barcelona, Spain
    • +16 more
    Jan 18, 2023

    Prostate Cancer, Castrate Sensitive Prostate Cancer, Oligometastatic Disease Trial in Ann Arbor (drug, radiation, biological)

    Recruiting
    • Prostate Cancer
    • +2 more
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Jun 1, 2021

    'OLAP' (OLAparib Regulatory Post-marketing Surveillance)

    Recruiting
    • Ovarian Cancer
    • +3 more
      • Busan, Korea, Republic of
      • +17 more
      Jan 9, 2023

      Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

      Not yet recruiting
      • Breast Cancer
      • +7 more
      • (no location specified)
      Sep 26, 2023

      Gastric Cancer, GastroEsophageal Cancer Trial in Aurora, Colorado Springs, Highlands Ranch (Pembrolizumab, Olaparib,

      Recruiting
      • Gastric Cancer
      • GastroEsophageal Cancer
      • Aurora, Colorado
      • +2 more
      Jan 4, 2023

      Endometrial Cancer Trial in Hong Kong (Olaparib)

      Not yet recruiting
      • Endometrial Cancer
      • Hong Kong, Hong Kong
        The University of Hong Kong
      Apr 2, 2022

      Castration-Resistant Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (Olaparib)

      Recruiting
      • Castration-Resistant Prostate Carcinoma
      • Prostate Adenocarcinoma
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Aug 23, 2022

      Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

      Not yet recruiting
      • Advanced Breast Cancer
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Sep 12, 2022

      Early-stage Breast Cancer Trial in Heidelberg (Atezolizumab 1200 mg in 20 ML Injection, Inavolisib, Ipatasertib)

      Not yet recruiting
      • Early-stage Breast Cancer
      • Atezolizumab 1200 mg in 20 ML Injection
      • +5 more
      • Heidelberg, Baden-Wuerttemberg, Germany
        National Center for Tumor Diseases
      Sep 13, 2022

      Cervical Cancer Trial in Hidaka (Pembrolizumab, Olaparib)

      Active, not recruiting
      • Cervical Cancer
      • Hidaka, Saitama, Japan
        Saitama Medical Uiversity International Medical Center
      Aug 8, 2022

      Ovary Cancer Trial in Poznan (Lynparza® (AstraZeneca Pharma Poland Sp. z o.o.), Lynparza)

      Recruiting
      • Ovary Cancer
      • Lynparza® (AstraZeneca Pharma Poland Sp. z o.o.)
      • Lynparza
      • Poznań, Poland
        University od Medical Sciences
      Oct 13, 2021

      Breast Cancer Trial in Spain (Olaparib)

      Terminated
      • Breast Cancer
      • Barcelona, Spain
      • +7 more
      Jan 18, 2023